The typical treatment of toxoplasmosis is a combination of pyrimethamine and sulfadiazine as two different antimicrobials which inhibit the dihydrofolate reductase (DHFR) and block the folic acid synthesis, respectively (14). The gene discussed is DHFR; the disease is toxoplasmosis.